Cargando…
Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency
Esophageal cancer (EC) threatens many lives in China, especially in areas with high incidences of EC. Our previous studies proved that zinc deficiency (ZD) promotes the cell cycle, thus promoting the progression of EC in areas with a high incidence of EC. Artesunate could inhibit the cell cycle, the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133444/ https://www.ncbi.nlm.nih.gov/pubmed/35646662 http://dx.doi.org/10.3389/fonc.2022.871483 |
_version_ | 1784713569574584320 |
---|---|
author | Jin, Jing Guo, Dongli Wang, Yingying Jiao, Wenpeng Li, Daojuan He, Yutong |
author_facet | Jin, Jing Guo, Dongli Wang, Yingying Jiao, Wenpeng Li, Daojuan He, Yutong |
author_sort | Jin, Jing |
collection | PubMed |
description | Esophageal cancer (EC) threatens many lives in China, especially in areas with high incidences of EC. Our previous studies proved that zinc deficiency (ZD) promotes the cell cycle, thus promoting the progression of EC in areas with a high incidence of EC. Artesunate could inhibit the cell cycle, thereby inhibiting the progression of EC. In this study, we first demonstrated the mechanism by which artesunate inhibits EC in vitro and then demonstrated that artesunate could reverse the ZD-promoted progression of EC before EC occurred in vivo. The results showed that artesunate could inhibit the cell cycle, metastasis, and glycolysis of EC cells. Artesunate could target HK1, promote HK1 degradation, and reduce the levels of HIF-1α and PKM2 expression, which are key glycolysis enzymes. The in vivo results showed that ZD could increase the expression of HK1 and increase the incidence of EC. Artesunate reduced the incidence of EC and decreased the level of HK1 expression before EC occurred. Artesunate has an anti-EC effect by inhibiting aerobic glycolysis and has the potential to be a drug that prevents EC in areas with a high risk of EC. |
format | Online Article Text |
id | pubmed-9133444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91334442022-05-27 Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency Jin, Jing Guo, Dongli Wang, Yingying Jiao, Wenpeng Li, Daojuan He, Yutong Front Oncol Oncology Esophageal cancer (EC) threatens many lives in China, especially in areas with high incidences of EC. Our previous studies proved that zinc deficiency (ZD) promotes the cell cycle, thus promoting the progression of EC in areas with a high incidence of EC. Artesunate could inhibit the cell cycle, thereby inhibiting the progression of EC. In this study, we first demonstrated the mechanism by which artesunate inhibits EC in vitro and then demonstrated that artesunate could reverse the ZD-promoted progression of EC before EC occurred in vivo. The results showed that artesunate could inhibit the cell cycle, metastasis, and glycolysis of EC cells. Artesunate could target HK1, promote HK1 degradation, and reduce the levels of HIF-1α and PKM2 expression, which are key glycolysis enzymes. The in vivo results showed that ZD could increase the expression of HK1 and increase the incidence of EC. Artesunate reduced the incidence of EC and decreased the level of HK1 expression before EC occurred. Artesunate has an anti-EC effect by inhibiting aerobic glycolysis and has the potential to be a drug that prevents EC in areas with a high risk of EC. Frontiers Media S.A. 2022-05-12 /pmc/articles/PMC9133444/ /pubmed/35646662 http://dx.doi.org/10.3389/fonc.2022.871483 Text en Copyright © 2022 Jin, Guo, Wang, Jiao, Li and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Jin, Jing Guo, Dongli Wang, Yingying Jiao, Wenpeng Li, Daojuan He, Yutong Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency |
title | Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency |
title_full | Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency |
title_fullStr | Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency |
title_full_unstemmed | Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency |
title_short | Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency |
title_sort | artesunate inhibits the development of esophageal cancer by targeting hk1 to reduce glycolysis levels in areas with zinc deficiency |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133444/ https://www.ncbi.nlm.nih.gov/pubmed/35646662 http://dx.doi.org/10.3389/fonc.2022.871483 |
work_keys_str_mv | AT jinjing artesunateinhibitsthedevelopmentofesophagealcancerbytargetinghk1toreduceglycolysislevelsinareaswithzincdeficiency AT guodongli artesunateinhibitsthedevelopmentofesophagealcancerbytargetinghk1toreduceglycolysislevelsinareaswithzincdeficiency AT wangyingying artesunateinhibitsthedevelopmentofesophagealcancerbytargetinghk1toreduceglycolysislevelsinareaswithzincdeficiency AT jiaowenpeng artesunateinhibitsthedevelopmentofesophagealcancerbytargetinghk1toreduceglycolysislevelsinareaswithzincdeficiency AT lidaojuan artesunateinhibitsthedevelopmentofesophagealcancerbytargetinghk1toreduceglycolysislevelsinareaswithzincdeficiency AT heyutong artesunateinhibitsthedevelopmentofesophagealcancerbytargetinghk1toreduceglycolysislevelsinareaswithzincdeficiency |